New Ray Medicine International Holding Limited's latest marketcap:
As of 06/23/2025, New Ray Medicine International Holding Limited's market capitalization has reached $7.24 M. According to our data, New Ray Medicine International Holding Limited is the 41773th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 7.24 M |
| Revenue (ttm) | 11.96 M |
| Net Income (ttm) | -3,949,195.42 |
| Shares Out | 1.67 B |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/28/2025 |
New Ray Medicine International Holding Limited's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/23/2025 | HK$7.24 M | -24.44% | 41773 |
| 12/31/2024 | HK$75.23 M | -10% | 38144 |
| 12/29/2023 | HK$83.59 M | -47.37% | 36814 |
| 12/30/2022 | HK$158.83 M | -77.65% | 32522 |
| 10/04/2017 | HK$710.53 M | 373.94% | 18482 |
| 12/30/2016 | HK$149.92 M | -50.63% | 23365 |
| 12/31/2015 | HK$303.66 M | -35.45% | 19353 |
| 12/31/2014 | HK$470.4 M | 16525 |
Company Profile
About New Ray Medicine International Holding Limited
New Ray Medicine International Holding Limited is an investment holding company specializing in the distribution and trading of pharmaceutical products, primarily in the People’s Republic of China. Established in 2001 and headquartered in Hangzhou, the company provides a diverse range of medical solutions, including marketing and promotion services.
Key Offerings
The company supplies a comprehensive portfolio of pharmaceutical products, such as:
- Injections, capsules, and tablets for various medical conditions
- Drugs targeting muscular dystrophy, cardiomyopathy, and cardiovascular diseases
- Treatments for hepatitis, liver cirrhosis, and immune disorders
- Medications for respiratory, urinary, and digestive system infections
- Solutions for intra-abdominal, bone, joint, and soft tissue infections
Core Services
In addition to pharmaceutical distribution, New Ray Medicine provides:
- Marketing and promotional support for pharmaceutical products
- Specialized treatments for chronic and acute medical conditions
With over two decades of experience, New Ray Medicine continues to serve as a trusted provider in China's healthcare sector.
Frequently Asked Questions
-
What is New Ray Medicine International Holding Limited's (HKG-6108) current market cap?As of 06/23/2025, New Ray Medicine International Holding Limited (including the parent company, if applicable) has an estimated market capitalization of $7.24 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does New Ray Medicine International Holding Limited (HKG-6108) rank globally by market cap?New Ray Medicine International Holding Limited global market capitalization ranking is approximately 41773 as of 06/23/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.